A Novel Diabetic Retinopathy Screening Model based on Pathology Services (Ret-Path) for People with Diabetes.

基于病理学服务 (Ret-Path) 的新型糖尿病视网膜病变筛查模型，适用于糖尿病患者。

• 批准号: nhmrc : 1012454
• 负责人: A/Pr Ecosse Lamoureux
• 金额: $ 50.96万
• 依托单位: Centre for Eye Research Australia Ltd
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/novel-diabetic-retinopathy-people-diabetes/109661
• 关键词: Novel; Diabetic; Retinopathy; Screening; Model

Most vision loss from diabetic retinopathy, a severe complication of diabetes, can be prevented by early detection. However, with no recognized eye screening procedure, up to half of Australians with diabetes do not have a regular eye check. We have successfully piloted a new eye screening model using pathology centres as an opportunistic catchment point. In this project, we will demonstrate the overall effectiveness and economic benefits of this novel eye screening model in urban and rural Victoria for people with diabtetes.

糖尿病视网膜病变是糖尿病的一种严重并发症，大多数视力丧失可以通过早期发现来预防。然而，由于没有公认的眼部筛查程序，多达一半的澳大利亚糖尿病患者没有定期进行眼部检查。我们已成功地试行了一种新的眼科筛查模式，利用病理中心作为一个机会性的汇集点。在这个项目中，我们将证明这种新的眼睛筛查模式在维多利亚城市和农村的糖尿病患者的整体有效性和经济效益。